Rock Springs Capital Management LP Q1 2024 Filing
Filed May 15, 2024
Portfolio Value
$3.9T
Holdings
113
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (113 positions)
| Stock | Value |
|---|---|
2L9BLUEPRINT MEDICINES CORP | $237.0M |
IMCRIMMUNOCORE HLDGS PLC | $153.9M |
NBIXNEUROCRINE BIOSCIENCES INC | $145.5M |
EVHEVOLENT HEALTH INC | $130.8M |
ISRGINTUITIVE SURGICAL INC | $119.1M |
UNHUNITEDHEALTH GROUP INC | $113.8M |
PENPENUMBRA INC | $112.7M |
IDXXIDEXX LABS INC | $96.8M |
ACHCACADIA HEALTHCARE COMPANY IN | $93.3M |
ARGXARGENX SE | $90.3M |
BSXBOSTON SCIENTIFIC CORP | $84.4M |
RAREULTRAGENYX PHARMACEUTICAL IN | $82.9M |
DC4DEXCOM INC | $82.8M |
LLYELI LILLY & CO | $80.3M |
FRPTFRESHPET INC | $76.8M |
MDGLMADRIGAL PHARMACEUTICALS INC | $76.4M |
EXASEXACT SCIENCES CORP | $73.2M |
AFWALIGN TECHNOLOGY INC | $72.1M |
RYTMRHYTHM PHARMACEUTICALS INC | $66.0M |
EWEDWARDS LIFESCIENCES CORP | $61.9M |
KYMRKYMERA THERAPEUTICS INC | $61.2M |
TCE2CELLDEX THERAPEUTICS INC NEW | $57.6M |
PHRPHREESIA INC | $56.6M |
PODDINSULET CORP | $54.8M |
WSTWEST PHARMACEUTICAL SVSC INC | $54.3M |
XENEXENON PHARMACEUTICALS INC | $54.1M |
AGLAGILON HEALTH INC | $53.9M |
MRUSMERUS N V | $51.6M |
AGIOAGIOS PHARMACEUTICALS INC | $51.6M |
HUMHUMANA INC | $51.1M |
MIRMMIRUM PHARMACEUTICALS INC | $46.6M |
IRTCIRHYTHM TECHNOLOGIES INC | $45.5M |
SWAVUSDSHOCKWAVE MED INC | $44.0M |
ASNDASCENDIS PHARMA A/S | $43.8M |
SRPTSAREPTA THERAPEUTICS INC | $42.4M |
AZTAAZENTA INC | $41.9M |
ALNYALNYLAM PHARMACEUTICALS INC | $41.3M |
—OLINK HLDG AB | $39.4M |
IMVTIMMUNOVANT INC | $37.2M |
ACCDEURACCOLADE INC | $37.1M |
AKROAKERO THERAPEUTICS INC | $32.8M |
OSCROSCAR HEALTH INC | $31.4M |
PCRXPACIRA BIOSCIENCES INC | $30.8M |
RVMDREVOLUTION MEDICINES INC | $29.8M |
LFSTLIFESTANCE HEALTH GROUP INC | $29.5M |
SGRYSURGERY PARTNERS INC | $29.4M |
WRBYWARBY PARKER INC | $28.3M |
INZYINOZYME PHARMA INC | $28.2M |
INSPINSPIRE MED SYS INC | $28.0M |
LEGNLEGEND BIOTECH CORP | $28.0M |
MREOMEREO BIOPHARMA GROUP PLC | $26.9M |
TVTXTRAVERE THERAPEUTICS INC | $26.4M |
CERE1EURCEREVEL THERAPEUTICS HLDNG I | $23.2M |
IRONDISC MEDICINE INC | $22.6M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $21.8M |
VKTXVIKING THERAPEUTICS INC | $21.4M |
DVAXDYNAVAX TECHNOLOGIES CORP | $20.8M |
ZLABZAI LAB LTD | $20.8M |
MGNXMACROGENICS INC | $19.2M |
NVONOVO-NORDISK A S | $18.9M |
KRYSKRYSTAL BIOTECH INC | $18.5M |
BCRXBIOCRYST PHARMACEUTICALS INC | $17.8M |
GPCRSTRUCTURE THERAPEUTICS INC | $17.7M |
PHVSPHARVARIS N V | $17.4M |
PRTAPROTHENA CORP PLC | $15.5M |
NVROEURNEVRO CORP | $15.4M |
VERAVERA THERAPEUTICS INC | $14.7M |
—MERSANA THERAPEUTICS INC | $13.6M |
AM6AMICUS THERAPEUTICS INC | $13.6M |
CRNXCRINETICS PHARMACEUTICALS IN | $13.5M |
CRLCHARLES RIV LABS INTL INC | $13.1M |
BMRNBIOMARIN PHARMACEUTICAL INC | $13.0M |
DYNDYNE THERAPEUTICS INC | $12.8M |
JSPRJASPER THERAPEUTICS INC | $11.9M |
CMPXCOMPASS THERAPEUTICS INC | $10.9M |
EDAEDAP TMS S A | $10.8M |
MLYSMINERALYS THERAPEUTICS INC | $10.2M |
APLTAPPLIED THERAPEUTICS INC | $10.2M |
NUVLNUVALENT INC | $9.4M |
ABOSACUMEN PHARMACEUTICALS INC | $9.3M |
IMTXIMMATICS N.V | $8.9M |
NMRANEUMORA THERAPEUTICS INC. | $8.9M |
ELVNENLIVEN THERAPEUTICS INC | $7.5M |
CGONCG ONCOLOGY INC | $7.5M |
BHVNBIOHAVEN LTD | $6.9M |
FULCFULCRUM THERAPEUTICS INC | $6.9M |
AUTLAUTOLUS THERAPEUTICS PLC | $6.6M |
LUNGPULMONX CORP | $6.0M |
AUPHAURINIA PHARMACEUTICALS INC | $5.8M |
EPIEURESSA PHARMA INC | $5.7M |
PLRXPLIANT THERAPEUTICS INC | $5.7M |
BEAMBEAM THERAPEUTICS INC | $4.9M |
—VINCERX PHARMA INC | $4.5M |
KYTXKYVERNA THERAPEUTICS INC | $4.4M |
SGMTSAGIMET BIOSCIENCES INC | $4.2M |
GOSSGOSSAMER BIO INC | $3.9M |
GOSS 5 06/01/27GOSSAMER BIO INC | $3.8M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $3.8M |
ACRSACLARIS THERAPEUTICS INC | $3.4M |
CGENCOMPUGEN LTD | $3.3M |
Page 1 of 2Next